What's in OPKO IP Holdings II, Inc.'s pipeline?

OPKO IP Holdings II, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with OPKO IP Holdings II, Inc.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/opko-ip-holdings-ii-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

OPKO IP Holdings II, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OPKO IP Holdings II, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
CTAP101 Injection	CTAP101 Injection	phase 3	C1-esterase inhibitor (C1-INH) replacement therapy	C1-esterase inhibitor (C1-INH); complement and contact system regulation	Immunology / Rare Genetic Disorders

Therapeutic area mix

Immunology / Rare Genetic Disorders · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for OPKO IP Holdings II, Inc.:

Cite this brief

Drug Landscape (2026). OPKO IP Holdings II, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/opko-ip-holdings-ii-inc. Accessed 2026-05-17.